- Home
- CING vs DXST Comparison
CING vs DXST Comparison
Compare CING & DXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CING
- DXST
- Stock Information
- Founded
- CING 2012
- DXST 2011
- Country
- CING United States
- DXST China
- Employees
- CING N/A
- DXST N/A
- Industry
- CING Biotechnology: Pharmaceutical Preparations
- DXST
- Sector
- CING Health Care
- DXST
- Exchange
- CING Nasdaq
- DXST NYSE
- Market Cap
- CING 16.2M
- DXST 18.7M
- IPO Year
- CING 2021
- DXST 2025
- Fundamental
- Price
- CING $4.25
- DXST $1.30
- Analyst Decision
- CING Strong Buy
- DXST
- Analyst Count
- CING 4
- DXST 0
- Target Price
- CING $30.67
- DXST N/A
- AVG Volume (30 Days)
- CING 104.9K
- DXST 25.1K
- Earning Date
- CING 08-12-2025
- DXST 01-01-0001
- Dividend Yield
- CING N/A
- DXST N/A
- EPS Growth
- CING N/A
- DXST 13.11
- EPS
- CING N/A
- DXST 0.14
- Revenue
- CING N/A
- DXST $11,542,292.00
- Revenue This Year
- CING N/A
- DXST N/A
- Revenue Next Year
- CING N/A
- DXST N/A
- P/E Ratio
- CING N/A
- DXST $9.06
- Revenue Growth
- CING N/A
- DXST 22.18
- 52 Week Low
- CING $1.80
- DXST $0.85
- 52 Week High
- CING $20.83
- DXST $5.74
- Technical
- Relative Strength Index (RSI)
- CING 59.00
- DXST N/A
- Support Level
- CING $3.97
- DXST N/A
- Resistance Level
- CING $4.26
- DXST N/A
- Average True Range (ATR)
- CING 0.27
- DXST 0.00
- MACD
- CING 0.00
- DXST 0.00
- Stochastic Oscillator
- CING 74.56
- DXST 0.00
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.
About DXST DECENT HOLDING INC
Decent Holding Inc through its subsidiary specializes in the provision of wastewater treatment by cleansing the industrial wastewater, ecological river restoration and river ecosystem management by enhancing the water quality, as well as microbial products used for pollutant removal and water quality enhancement. Its main services and products include (1) wastewater treatment, (2) river water quality management, and (3) microbial products for water quality enhancement and pollutant cleansing purposes. The company's focus is on research and development (R&D) to sharpen its innovation edge.